logo
Loading...
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial

Medicine and Health

p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial

H. R. C. Shanks, K. Chen, et al.

Exciting research by Hayley R. C. Shanks and colleagues investigates the p75 neurotrophin receptor in Alzheimer's disease, revealing that the novel small molecule LM11A-31 potentially slows the disease's progression, despite no significant cognitive improvements. This work opens new avenues for treatment exploration.... show more
Introduction
Literature Review
Methodology
Key Findings
Discussion
Conclusion
Limitations

Related Publications

Explore these studies to deepen your understanding of the subject.

Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
Medicine and Health

Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial

A. J. Sanyal, L. M. Kaplan, et al.

A randomized controlled trial for response of microbiome network to exercise and diet intervention in patients with nonalcoholic fatty liver disease
Medicine and Health

A randomized controlled trial for response of microbiome network to exercise and diet intervention in patients with nonalcoholic fatty liver disease

R. Cheng, L. Wang, et al.

RANKL blockade for erosive hand osteoarthritis: a randomized placebo-controlled phase 2a trial
Medicine and Health

RANKL blockade for erosive hand osteoarthritis: a randomized placebo-controlled phase 2a trial

R. Wittoek, G. Verbruggen, et al.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 22+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny